Labeling of pancreatic islets with iron oxide nanoparticles for in vivo detection with magnetic resonance
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
18192927
DOI
10.1097/01.tp.0000297247.08627.ff
PII: 00007890-200801150-00025
Knihovny.cz E-zdroje
- MeSH
- barvení a značení metody MeSH
- beta-buňky patologie MeSH
- časové faktory MeSH
- kovové nanočástice * MeSH
- krysa rodu Rattus MeSH
- kultivované buňky MeSH
- Langerhansovy ostrůvky patologie MeSH
- magnetická rezonanční tomografie metody MeSH
- makrofágy patologie MeSH
- transplantace Langerhansových ostrůvků metody MeSH
- železité sloučeniny * MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- ferric oxide MeSH Prohlížeč
- železité sloučeniny * MeSH
In vitro labeling of pancreatic islets with iron nanoparticles enables their direct posttransplant visualization by magnetic resonance; however, there is still a discrepancy in the fate of iron nanoparticles. This study was performed to detail the labeling process, consequently to improve the labeling efficacy and to confirm safety for islet cells. The islets were visible on T2*-weighted magnetic resonance images as hypointense spots immediately after 1-hr cultivation. Although at this time already the sufficient superparamagnetic effect was achieved, most of the particles were deposed in islet macrophages and only later were they found in endosomes of endocrine islet cells. The iron content depended on length of culture period. The labeled islets showed an intact ultrastructure, responded normally to glucose stimulation in vitro, and were able to treat experimental diabetes. For purpose of subsequent magnetic resonance imaging, a 24-hr culture with ferucarbotran leads to sufficient labeling with no apparent adverse effect on beta cell morphology or function.
Citace poskytuje Crossref.org
Cationic fluorinated micelles for cell labeling and 19F-MR imaging
MR beyond diagnostics at the ESMRMB annual meeting: MR theranostics and intervention
Imaging the Beta-cell mass: why and how